1 – 10 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Wnt5a is a TLR2/4-ligand that induces tolerance in human myeloid cells
(
- Contribution to journal › Article
-
Mark
SMAC mimetics promote NIK-dependent inhibition of CD4+ TH17 cell differentiation
(
- Contribution to journal › Article
- 2018
-
Mark
Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse
(
- Contribution to journal › Article
-
Mark
The immunomodulatory quinoline-3-carboxamide paquinimod reverses established fibrosis in a novel mouse model for liver fibrosis
(
- Contribution to journal › Article
- 2016
-
Mark
A new mouse model that spontaneously develops chronic liver inflammation and fibrosis
(
- Contribution to journal › Article
-
Mark
CD14 is a co-receptor for TLR4 in the S100A9-induced pro-inflammatory response in monocytes
(
- Contribution to journal › Article
-
Mark
The anti-tumor effect of the quinoline-3-carboxamide tasquinimod : Blockade of recruitment of CD11b+ Ly6Chi cells to tumor tissue reduces tumor growth
(
- Contribution to journal › Article
- 2015
-
Mark
S100A9 as a pharmacological target molecule in inflammation and cancer.
(
- Contribution to journal › Article
- 2014
-
Mark
Quinoline-3-carboxamides modulate primary T cell-dependent B cell responses but do not inhibit functional immunity.
(
- Contribution to journal › Article
- 2013
-
Mark
Common Interactions between S100A4 and S100A9 Defined by a Novel Chemical Probe.
(
- Contribution to journal › Article